Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00348205 · ClinicalTrials.gov registry record · NA

A Study to Evaluate the Safety and Effectiveness of the Technols 217z Zyoptix System for Hyperopia

A NA study of Astigmatism and Hyperopia, sponsored by Bausch & Lomb Incorporated.

Completed
Registry status
NA
Development phase
80
Enrollment target
1
Study location

NCT00348205 is a NA study of Astigmatism and Hyperopia that has completed, run by Bausch & Lomb Incorporated. The registered enrollment target is 80 participants, below the 104-participant average among 31 other Astigmatism trials with a reported enrollment target (23% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00348205, a NA study of Astigmatism and Hyperopia, has completed, sponsored by Bausch & Lomb Incorporated.

COMPLETED
Registry status
NA
Development phase
80 participants
Enrollment target
1
Study location

Study Summary

A study to demonstrate the safety and effectiveness of wavefront laser refractive surgery treatments for hyperopia and astigmatism.

Conditions Studied

Interventions

  • DEVICE Technolas 217z Zyoptix Laser

Study Locations (1)

New York

  • Bausch & Lomb - Rochester

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2005-06
Est. Completion 2009-03
Phase NA

Sponsor

Bausch & Lomb Incorporated

174 total trials

What the Registry Record Tells You About NCT00348205

The ClinicalTrials.gov registry entry for NCT00348205 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 104-participant average among 31 other Astigmatism trials with a reported enrollment target (23% lower). The listed sponsor is Bausch & Lomb Incorporated, which has 174 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Astigmatism appearing as the primary indexed condition, and to 1 intervention - of which Technolas 217z Zyoptix Laser is the first listed.

NCT00348205 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT00348205 about?

NCT00348205 is a clinical study titled "A Study to Evaluate the Safety and Effectiveness of the Technols 217z Zyoptix System for Hyperopia". A study to demonstrate the safety and effectiveness of wavefront laser refractive surgery treatments for hyperopia and astigmatism.

What is the current status of trial NCT00348205?

This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2005-06. Estimated completion is 2009-03.

What conditions does trial NCT00348205 study?

This clinical trial studies the following conditions: Astigmatism, Hyperopia.

What interventions are being tested in trial NCT00348205?

The interventions under investigation include: Technolas 217z Zyoptix Laser (DEVICE).

Who is sponsoring clinical trial NCT00348205?

This trial is sponsored by Bausch & Lomb Incorporated, which has 174 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00348205 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Astigmatism

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.